Celecoxib/tramadol

Add links
From English Wikipedia @ Freddythechick

Celecoxib/tramadol
Combination of
CelecoxibNonsteroidal anti-inflammatory drug (NSAID)
Tramadol hydrochlorideOpioid agonist
Clinical data
Trade namesSeglentis
Other namesE-58425
License data
Routes of
administration		By mouth
ATC code
Legal status
Legal status
Identifiers
KEGG

Celecoxib/tramadol sold under the brand name Seglentis, is a fixed-dose combination of the anti-inflammatory celecoxib and the opioid tramadol used for the management and treatment of pain.[1]

Developed by Spanish pharmaceutical company Esteve, it was approved for medical use in the United States in October 2021.[1][2][3]

References

  1. ^ 1.0 1.1 1.2 "Seglentis- celecoxib and tramadol hydrochloride tablet". DailyMed. Retrieved 8 January 2022.
  2. ^ "Seglentis: FDA-Approved Drugs". U.S. Food and Drug Administration. Retrieved 18 October 2021.
  3. ^ "Esteve Announces FDA Approval Of A Novel Co-Crystal Form Of Celecoxib And Tramadol For The Management Of Acute Pain". Esteve (Press release). 15 October 2021. Retrieved 18 October 2021.

External links

  • "Celecoxib". Drug Information Portal. U.S. National Library of Medicine.
  • "Tramadol hydrochloride". Drug Information Portal. U.S. National Library of Medicine.
  • Clinical trial number NCT03108482 for "Co-crystal E-58425 vs Tramadol and Celecoxib for Moderate to Severe Acute Pain After Bunionectomy. Phase III Clinical Trial." at ClinicalTrials.gov

Lua error in mw.title.lua at line 346: bad argument #2 to 'title.new' (unrecognized namespace name 'Portal').


Stub icon

This analgesic-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://enwiki.freddythechick.net/index.php?title=Celecoxib/tramadol&oldid=2815499"